Synthesis, Biological Evaluation, Molecular Docking and Kinetic Investigation of New 2,4,5‐Trisubstituted Imidazole Derivatives as Antidiabetic Agents
Authors:
- 16 August 2023
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 8 (31)
Abstract
A series of novel 2,4,5‐trisubstituted imidazole motifs have been synthesized by a magnetically‐tuned halloysite‐supported sulfonic acid catalyst. The prepared supported sulfonic acid catalyst was well characterized by High‐resolution transmission electron microscopy (HR‐TEM), Scanning electron microscopy (SEM), Energy dispersive X‐rays spectroscopy (EDS), Fourier transform infrared (FTIR), X‐ray powder diffraction (XRD), Thermogravimetric analysis (TGA), Brunauer–Emmett–Teller (BET), and Vibrating–sample magnetometry (VSM) techniques; and compounds were confirmed by 1 H, 13 C‐Nuclear magnetic resonance (NMR) and High resolution mass spectrometry (HRMS) techniques. The purity of compounds was established by High performance liquid chromatography (HPLC). All the prepared compounds were screened for their in vitro antidiabetic activity by using α ‐amylase and α ‐glucosidase inhibition assay taking acarbose as a reference standard and were found to exhibit significant α ‐amylase inhibitory potentials, whereas for α ‐glucosidase inhibition, compounds were equipotent to the reference standard. Compound bearing ferrocene moiety was identified as the strongest α ‐amylase inhibitor of the series with IC 50 =47.83±0.63 μM, a five‐fold more potency compared to acarbose (IC 50 =269.39±0.29 μM). The presence of substituents in the second position of imidazole pharmacophore plays a key role in inhibitory activity. To find the possible binding interaction of compounds, in silico molecular docking study was performed.Keywords
This publication has 49 references indexed in Scilit:
- Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitroExperimental and Toxicologic Pathology, 2013
- Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-oneEuropean Journal of Medicinal Chemistry, 2013
- Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 AgonistsJournal of Medicinal Chemistry, 2012
- Green fabrication of agar-conjugated Fe3O4magnetic nanoparticlesNanotechnology, 2010
- Catalyst-Free One-Pot Four Component Synthesis of Polysubstituted Imidazoles in Neutral Ionic Liquid 1-Butyl-3-methylimidazolium BromideJournal of Combinatorial Chemistry, 2010
- Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazolesEuropean Journal of Medicinal Chemistry, 2009
- Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic ActivityJournal of Medicinal Chemistry, 2009
- Study of Natural Halloysite from the Dragon Mine, Utah (USA)Zeitschrift für anorganische und allgemeine Chemie, 2009
- Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamidesBioorganic & Medicinal Chemistry Letters, 2008
- Antidiabetic Activity of Passive Nonsteroidal Glucocorticoid Receptor ModulatorsJournal of Medicinal Chemistry, 2005